PFE vs ABBV
PFE 与 ABBV 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | PFEPFIZER INC | ABBVAbbVie Inc. |
|---|---|---|
| 市值 | $158.05B | $462.52B |
| 市盈率(TTM) | 36.5 | 73.9 |
| 市净率 | 1.86 | — |
| 市销率 | 2.5x | 7.6x |
| 股息率 | 6.18% | 2.52% |
| 营收 | $63.70B(TTM) | $61.16B(TTM) |
| 营收同比增长 | -1.6% | 8.6% |
| 净利润 | $4.33B(TTM) | $6.31B(TTM) |
| 净利同比增长 | -3.2% | -1.2% |
| 每股收益(稀释) | $0.76(TTM) | $3.54(TTM) |
| 息税前利润率 | 16.3% | 24.6% |
| 净资产收益率 | 9.1% | — |
| 投入资本回报率 | 6.9% | 18.6% |
| 一年总回报 | +23.3% | +22.9% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:PFE vs ABBV
| 指标 | PFE | ABBV |
|---|---|---|
| 期末价值 | $13.3K | $63.5K |
| 总回报 | +32.8% | +534.9% |
| 年化收益 (CAGR) | +2.8% | +19.6% |
| 波动率 | 23.9% | 25.9% |
| 夏普比率 | 0.06 | 0.67 |
| 索提诺比率 | 0.09 | 0.93 |
| 最大回撤 | -59.0% | -45.1% |
基于 2600 个共同交易日,2016-05-11 → 2026-09-14 · 无风险利率 4.07%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)